⌘K

Home/Filings/4/0001209191-16-125621

4//SEC Filing

ZIOPHARM ONCOLOGY INC 4

Accession 0001209191-16-125621

$TCRTCIK 0001107421operating

View on SEC.gov Company Profile

Filed

Jun 2, 8:00 PM ET

Accepted

Jun 3, 4:23 PM ET

Size

4.8 KB

Accession

0001209191-16-125621

Insider Transaction Report

Form 4

Period: 2016-06-01

ZIOPHARM ONCOLOGY INCZIOP

BELBEL CAESAR J

EVP, Chief Legal Officer & Sec

Transactions

Tax Payment
Common Stock
2016-06-01$7.74/sh−6,667$51,603→ 117,534 total

Footnotes (1)

[F1]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001107421

Filing Metadata

Form type: 4
Filed: Jun 2, 8:00 PM ET
Accepted: Jun 3, 4:23 PM ET
Size: 4.8 KB

View on SEC.gov